Clinical Trial Update: Combination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating combination chemotherapy with bevacizumab for metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Federation Francophone de Cancerologie Digestive | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED